Patients begin to lose weight, often seeing steady, sustainable fat reduction. Increased satiety and appetite regulation, helping control food intake. Improved insulin sensitivity, reducing the need for additional diabetes medications
Summary: Bupropion and Saxenda together are not explicitly contraindicated in UK guidance, but the combination requires careful individual assessment and monitoring by a qualified healthcare professional
MEDVi offers guidance on what to do if you skip a dose or feel off track, with direct access to provider feedback
In addition to established endocrine mechanisms, such as glucose-dependent insulin secretion, delayed gastric emptying, and appetite suppression, GLP-1 RAs engage in complex bidirectional interactions with the intestinal ecosystem (58)
We understand how discouraging that can be
2025ZNSFSC1642)